Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Key Points Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) signalling plays a major part in fuel metabolism and in the regulation of body composition Obesity, particularly abdominal obesity, exerts a strong negative effect on the spontaneous pulsatile secretion of GH, which has been associated with adverse metabolic complications GH administration in individuals with abdominal obesity reduces visceral and total body adipose tissue mass, as well as levels of total and LDL cholesterol Increasing the endogenous pulsatile GH secretion in individuals with obesity has metabolic effects similar to those obtained by the administration of exogenous GH but potentially with less adverse effects on glucose metabolism Mouse models with altered GH signalling provide a useful means for a comparative analysis of GH action in obesity The role of the GH/IGF-1 axis in modifying obesity must be assessed in light of newly emerging data that highlight the complexity of adipose tissue This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 186,36 per year only 15,53 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Topology and paramaterisation files for the -Glu-FA are available in Zenodo [ MD trajectories are available in Zenodo [ Source data files for gels are available within the Supplementary Information file included with this manuscript
Sube tu rendimiento y tu volumen muscular con la creatina de siempre
Co-injecting both at the same time means both receptor systems are activated in the same physiological window, mimicking the endogenous GHRH-ghrelin co-release that occurs at the hypothalamic level during natural GH pulses
US$ 24.69
US$ 25.59
US$ 20.84
